SUPN
SUPN
US8684591089
Supernus Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.48B EUR
2.71B EUR
3B EUR
2.86B EUR
Enterprise Value
2.12B EUR
2.57B EUR
2.86B EUR
2.77B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
9.57x
--
--
--
Price to Sales
2.99x
3.26x
3.86x
5.02x
Price to Book
2.41x
2.62x
2.79x
2.69x
EV/Revenue
2.55x
3.09x
3.68x
4.86x
EV/EBITDA
19.18x
45.07x
41.03x
58.86x
Price to FCF (P/FCF)
29.36x
143.99x
36.48x
181.64x
EV/FCF
25.03x
136.55x
34.73x
176.08x
FCF Yield
3.41%
0.69%
2.74%
0.55%
ende